ArticleJournal of transplantation2011

The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review.

Carlos E Araya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.